We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Eye Care

Journal Scan / Consensus and Guidelines · January 29, 2014

Expert Recommendations for Use of Anti-TNF-α Agents in Ocular Inflammatory Disorders



Additional Info

Disclosure statements are available on the authors' profiles:

Expert Panel Recommendations for the Use of Anti-Tumor Necrosis Factor Biologic Agents in Patients With Ocular Inflammatory Disorders
Ophthalmology 2013 Dec 17;[EPub Ahead of Print], G Levy-Clarke, DA Jabs, RW Read, JT Rosenbaum, A Vitale, RN Van Gelder

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading